|
⚲
|
| Keyboard |
| First Manhattan Co LLC
✚
|
|
|---|---|
| CRD # | 325281 |
| SEC # | 801-12411 |
| CIK # | 0000728083 |
| AUM | 38.09 B (2026-04-01) |
| Employees | 147 (35% Investors, 64% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-756-3300 |
| Address | 399 Park Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Microsoft Corp | 1.6 | ||
| Apple Inc | 1.3 | ||
| Alphabet Inc | 1.2 | ||
| ASML Holding NV | 1.0 | ||
| Brookfield Asset Management Inc | 0.9 | ||
| Autozone Inc | 0.9 | ||
| KKR & Co LP | 0.9 | ||
| Amazon Com Inc | 0.7 | ||
| Broadcom Inc | 0.7 | ||
| Oracle Corp | 0.6 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | FM Broadway LP | [2025-03-31] | 60.8 M | |
| Filed 2024-04-05 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | FMC New Venture Access Fund LP | [2024-03-29] | 66.7 M | 19.4 M |
| Filed 2025-02-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | FM Civan Investment II LP | 2021-03-31 | 8.5 M | |
| PE | FM Civan Investment LP | 2021-03-31 | 56.9 M | |
| Other | FMC Research Fund LP | 2021-03-31 | 46.8 M | |
| PE | FMZ Ventures Fund I LP | 2021-03-31 | 99.2 M | |
| HF | Greenleaf Partners Fund LP | [2020-03-26] | 22.5 M | 21.9 M |
| Filed 2026-01-20 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $50,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | FM First China Portfolio LP | [2014-03-20] | 22.0 M | 85.6 M |
| Filed 2025-12-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $50,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| Other | First Biomed LP | 2012-03-27 | ||
| Other | First Biomed Portfolio LP | 2012-03-27 | ||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 2,252 | 0.6 |
| (b) Individuals (high net worth individuals) | 3,828 | 33.3 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 2 | 0.2 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 9 | 0.9 |
| (g) Pension and profit sharing plans | 95 | 1.5 |
| (h) Charitable organizations | 108 | 1.6 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6,294 | 38.1 |
| By Discretionary | ||
| Discretionary | 6,104 | 35.7 |
| Non-Discretionary | 190 | 2.4 |
| Total | 6,294 | 38.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.7 | |
| United States Persons | 36.4 | |
| Total | 6,294 | 38.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Adam Schwartz | Executive Officer | 254 | 4 | |
| Xiang Huang | Executive Officer | 5 | 3 | |
| Andrew Aspen | Executive Officer | 11 | 2 | |
| First Manhattan Co LLC | Promoter | 11 | 2 | |
| First Manhattan Co | Promoter | 7 | 2 | |
| Matthew Shaver | Executive Officer | 3 | 2 | |
| Alvaro Spinola | Executive Officer | 2 | 2 | |
| First Manhattan Co Incorporated | Promoter | 1 | 1 | |
| David Yazdan | Executive Officer | 1 | 1 | |
| Zachary Wydra | Executive Officer | 1 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0000728083] | |
| 3 | [0000728083] | |
| SC 13D | [0000728083] | |
| SC 13G | [0000728083] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $29.9B |
| Serves | Institutional, Retail |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 254900GPT1NYUZA39V60 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vivus Inc | |
| Norton David Y | |
| Keating Melvin L | |
| Biro Jon C | |
| First Manhattan Co LLC | |
| Rosenman Herm | |
| First BioMed Management Associates LLC |
| Comparable Firms | State | AUM |
|---|---|---|
|
Apogem Capital LLC
✚
|
NY | 43.82 B |
|
Investure LLC
✚
|
VA | 38.52 B |
|
Rockefeller & Co LLC
✚
|
NY | 36.76 B |
|
Oppenheimer & Co Inc
✚
|
NY | 36.71 B |
|
Select Equity Group LP
✚
|
NY | 36.38 B |
|
Voya Alternative Asset Management LLC
✚
|
NY | 34.01 B |
|
First Pacific Advisors LP
✚
|
CA | 32.00 B |
|
Muzinich & Co Inc
✚
|
NY | 31.27 B |
|
BTG Pactual Asset Management US LLC
✚
|
NY | 30.11 B |
|
JP Morgan Alternative Asset Management Inc
✚
|
NY | 29.73 B |